DermTech Inc (NAS:DMTK)
$ 0.638 0.018 (2.9%) Market Cap: 22.31 Mil Enterprise Value: 20.21 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 44/100

Q4 2022 DermTech Inc Earnings Call Transcript

Mar 02, 2023 / 10:00PM GMT
Release Date Price: $3.8 (-7.77%)
Operator

Good day and thank you for standing by. Welcome to DermTech's fourth-quarter 2022 financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Steve Kunszabo, Head of Investor Relations.

Steve Kunszabo
DermTech, Inc. - Senior Director, IR

Thank you. Welcome to DermTech's fourth-quarter 2022 earnings call. Joining me on today's call are Dr. John Dobak, our President and Chief Executive Officer; and Kevin Sun, our Chief Financial Officer.

Our call today will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact are considered forward-looking statements, including projections of future performance based on management's expectations as of today, and are subject to various factors, assumptions, risks, and uncertainties, which change over time.

Actual results could differ materially

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot